US OptionsDetailed Quotes
VKTX241129P65000
- 10.74
- -1.44-11.82%
15min DelayClose Nov 27 15:59 ET
11.78High10.74Low
11.78Open12.18Pre Close3 Volume41 Open Interest65.00Strike Price3.33KTurnover405.15%IV0.46%PremiumNov 29, 2024Expiry Date10.49Intrinsic Value100Multiplier0DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type-0.8917Delta0.0253Gamma5.02Leverage Ratio-1.6484Theta-0.0006Rho-4.48Eff Leverage0.0034Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet